Show simple item record

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

dc.contributor.authorSekulic, Aleksandar
dc.contributor.authorMigden, Michael R
dc.contributor.authorBasset-Seguin, Nicole
dc.contributor.authorGarbe, Claus
dc.contributor.authorGesierich, Anja
dc.contributor.authorLao, Christopher D
dc.contributor.authorMiller, Chris
dc.contributor.authorMortier, Laurent
dc.contributor.authorMurrell, Dedee F
dc.contributor.authorHamid, Omid
dc.contributor.authorQuevedo, Jorge F
dc.contributor.authorHou, Jeannie
dc.contributor.authorMcKenna, Edward
dc.contributor.authorDimier, Natalie
dc.contributor.authorWilliams, Sarah
dc.contributor.authorSchadendorf, Dirk
dc.contributor.authorHauschild, Axel
dc.date.accessioned2019-04-21T03:17:09Z
dc.date.available2019-04-21T03:17:09Z
dc.date.issued2019-04-18
dc.identifier.citationBMC Cancer. 2019 Apr 18;19(1):366
dc.identifier.urihttps://doi.org/10.1186/s12885-019-5568-6
dc.identifier.urihttps://hdl.handle.net/2027.42/148648
dc.description.abstractFollowing publication of the original article [1], it was reported that the legend for Fig. 1 was incomplete. The complete figure legend is:
dc.titleCorrection to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
dc.typeArticleen_US
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/148648/1/12885_2019_Article_5568.pdf
dc.language.rfc3066en
dc.rights.holderThe Author(s).
dc.date.updated2019-04-21T03:17:11Z
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.